Venture-Med Angel Investment Group is a membership organization of accredited investors dedicated to funding and mentoring new healthcare startup companies. We focus on medical devices, healthcare IT, diagnostic biopharma and digital health technologies that will enhance patient safety and outcomes. Membership Inquiry.
We provide unparalleled access, mentorship and support to early-stage companies that have IP, a strong team, domain expertise and vision. Learn more about our Screening and Evaluation Process.
We are very excited to bring the best healthcare startup companies to light. These are companies that have IP, a seasoned and experienced team and are tackling big problems with innovative solutions. We also bring very knowledgable featured speakers to our events.
View Upcoming Events.
WASHINGTON (Reuters) - U.S. President Donald Trump and House of Representatives leaders pushed on Wednesday for votes for their plan to overhaul Obamacare and said they were making progress in their efforts to win over conservative Republicans who have demanded changes to the legislation. […]
VIENNA (Reuters) - Austrian poultry will be allowed outdoors as of Saturday as the threat from bird flu is fading, the country's health ministry said, lifting a restriction put in place more than two months ago. […]
Tel Aviv (Reuters) - Israel, a leader in marijuana research and health technology, is attracting international investment as it tries to position itself as a cutting-edge exporter in the rapidly-growing market for medical-grade cannabis. […]
(Reuters) - Uncertainty surrounding the Republican plan to replace Obamacare is forcing some U.S. hospitals to delay expansion plans, cut costs, or take on added risk to borrow money for capital investment projects, dealing an economic blow to these facilities and the towns they call home. […]
A federal court this week certified a class of NuVasive Inc. (NSDQ:NUVA) investors in a suit alleging that the company lost share value after it hid a kickback scheme. A judge in the US District Court for the Southern District of California this week granted a motion for class certification, appointing Brad Mass and Daniel Popov as class representatives, acc […]
Biosensors International said today it enrolled the 1st patient in a pivotal US study of its BioFreedom drug-coated stent. The Singapore-based company’s Leaders Free II study is an ongoing trial examining the use of the BioFreedom DCS in patients at high bleeding risk who receive an ultra-short dual anti-platelet drug regimen of 1 per month. “We […] The post […]
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in […] The post MassDevice.com +5 | The top 5 […]
Clinical research sponsors continue to outsource the management of their clinical trials, spending millions of dollars for a pivotal phase and significant risk medical device trial. Choosing a clinical research organization with compliance expertise will protect your investment and ensure your product is ultimately approved. The right CRO should understand […]
...s employees worldwide are building upon the company's rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care. View source version on businesswire.com: http://www.businesswire.com/news/home/20170322006081/en/ [ Back ... […]
...WeFund Health WeFund Health is a disruptive health technology investment platform that intelligently matches healthtech opportunities, with qualified investors, and healthcare innovation centers across the world. Our healthtech investment platform provides a transparent vehicle for deal assesment in a controlled environment ... […]
...s employees worldwide are building upon the company's rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care. 1 "Data and Statistics." WHO/Europe . World Health Organization, 01 Mar. 2017. Web. 01 Mar ... […]
...s employees worldwide are building upon the company's rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care. FLOSEAL Hemostatic Matrix Indication FLOSEAL Matrix is indicated in surgical procedures (other than ophthalmic) as ... […]